Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«MedImmune

Below is an extended MedImmune research listing. Click here to return to the MedImmune main Biocorporate entry.

Recent Publications by MedImmune:

Increased vagal airway tone in fatal asthma.
Slow-onset asthma deaths are characterized by eosinophilic airway...
13th November, 2009
MedImmune, LLC, Clinical Development, One MedImmune Way, Office # 45C20, Med Hypotheses. 2009 Nov 9.
DOI Direct Link
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
EphA2 is a receptor tyrosine kinase that has been shown to be...
6th November, 2009
MedImmune, Inc., Gaithersburg, MD 20878, USA. Neoplasia. 2009 Jun;11(6):509-17, 2 p following 517.
Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.
BACKGROUND: Human metapneumovirus (HMPV) is an important cause of acute...
5th November, 2009
Department of Pediatrics, Vanderbilt University School of Medicine, Virol J. 2009 Sep 9;6:138.
DOI Direct Link
The impact of continuous renal replacement therapy on drug therapy.
Critically ill patients with multisystem organ failure often require daily...
5th November, 2009
Medical Information, MedImmune, Inc., Frederick, Maryland, USA. Clin Pharmacol Ther. 2009 Nov;86(5):562-5. Epub 2009 Sep 2.
DOI Direct Link
Generation of live attenuated novel influenza A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.
Several live attenuated influenza A/California/7/09 (H1N1) candidate...
30th October, 2009
MedImmune, 319 North Bernardo Ave, Mountain View, CA 94043. J Virol. 2009 Oct 28.
DOI Direct Link
The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators.
Monoclonal antibodies are traditionally used to block the function of a...
29th October, 2009
Department of Antibody Discovery and Protein Engineering, MedImmune, One J Mol Biol. 2009 Oct 30;393(3):672-92. Epub 2009 Aug 20.
DOI Direct Link
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
OBJECTIVE: Type I interferons (IFNs) play an important role in the...
18th August, 2009
MedImmune, Arthritis Rheum. 2009 Jun;60(6):1785-96.
DOI Direct Link
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib.
IPI-504 is a novel, highly soluble small-molecule inhibitor of heat shock...
13th August, 2009
Department of Pre-Clinical Oncology, MedImmune, Gaithersburg, MD 20878, Mol Cancer Ther. 2009 Aug;8(8):2131-41. Epub 2009 Aug 11.
DOI Direct Link
GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection.
Although influenza pandemics occur infrequently, they are unpredictable....
31st July, 2009
MedImmune, Clinical Testing Laboratories, Mountain View, CA 94043, USA. Curr Opin Mol Ther. 2009 Jun;11(3):337-45.
Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
A commercial kit assay of tartrate-resistant acid phosphatase (TRACP 5b)...
30th July, 2009
Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, CA 91320, J Pharm Biomed Anal. 2009 Jul 12;49(5):1203-12. Epub 2009 Mar 20.
DOI Direct Link
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers.
BACKGROUND: Interleukin-9 (IL-9) is involved in pathogenic aspects of the...
28th July, 2009
Medlmmune, LLC, Gaithersburg, Clin Ther. 2009 Apr;31(4):728-40.
DOI Direct Link
Use of MDCK cells for production of live attenuated influenza vaccine.
To develop a cell-based live attenuated influenza vaccine (LAIV)...
30th June, 2009
MedImmune, LLC., 3055 Patrick Henry Drive, Santa Clara, CA 95054, United Vaccine. 2009 Oct 30;27(46):6460-3. Epub 2009 Jun 24.
DOI Direct Link
Challenges in developing a pediatric RSV vaccine.
RSV bronchiolitis is the leading cause of infant hospitalization in...
27th June, 2009
Research Department, MedImmune, Mountain View, CA, USA. Hum Vaccin. 2009 Sep;5(9):582-91. Epub 2009 Sep 28.
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.
A live attenuated influenza vaccine (LAIV) is currently approved in the...
9th June, 2009
MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA. Influenza Other Respi Viruses. 2008 Nov;2(6):193-202.
DOI Direct Link
Phase-I study medi-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children.
A live, attenuated respiratory syncytial virus and parainfluenza virus...
2nd June, 2009
From the *MedImmune, Gaithersburg, MD; and daggerUniversity Physicians Pediatr Infect Dis J. 2009 Jul;28(7):655-8.
DOI Direct Link

«MedImmune

This page contained an extended MedImmune research listing. Click here to return to the MedImmune main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.